Minaguchi 1986.
Study characteristics | ||
Methods | Trial design: Randomised, multi‐centre study | |
Participants | Participants: 191 women were randomised and analysed. Mean age: not stated Inclusion criteria:
Exclusion criteria:
Setting: Japan Timing: not stated |
|
Interventions | Buserelin 300 mcg once daily intranasally for 6 months (n = 69) versus Buserelin 300 mcg twice daily intranasally for 6 months (n = 59) versus Buserelin 300 mcg three times a day intranasally for 6 months (n = 63) |
|
Outcomes |
|
|
Notes | Intention‐to‐treat analysis: not stated Sample size calculation: not stated Funding: not stated Note previous version: Authors contacted regarding methods and data; awaiting response |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | No details were provided of method used to generate the randomisation sequence. |
Allocation concealment (selection bias) | Unclear risk | "Envelope". No further details were provided of method used to conceal treatment group allocation. |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | No information about blinding; open‐label study |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No information about blinding; open‐label study |
Incomplete outcome data (attrition bias) All outcomes | Low risk | All women who were randomised were analysed. |
Selective reporting (reporting bias) | Low risk | The study protocol was not available but it was clear that the published reports included all expected outcomes, including those that were prespecified. |
Other bias | Low risk | No other risk of bias detected |